Primary human parvovirus B19 infection in an HIV infected patient on highly active antiretroviral therapy

Sexually Transmitted Infections

Volumn 79, Issue 4, 2003, Pages 336-

  Clarke, J ^a   Lee, J D ^b  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b MID YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; LAMIVUDINE; ZIDOVUDINE;

ADULT; ARTHRALGIA; ARTHRITIS; ARTICLE; BONE MARROW SUPPRESSION; CASE REPORT; FEVER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNE DEFICIENCY; MALE; PARVOVIRUS; RASH;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANEMIA; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ERYTHEMA INFECTIOSUM; HEMOGLOBINS; HUMANS; MALE;

EID: 0042388345     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.79.4.336     Document Type: Article

References (5)

1. Carcelain G, Debre P, Autran B. Reconstitution of CD4+ lymphocytes in HIV-infected individuals following antiretroviral therapy. Curr Opin Immun 2001;13:483-8.
2. Fuller A, Moaven I, Spelmaan D, et al. Parvovirus B19 in HIV infection: a treatable cause of anaemia. Pathology 1996;28:277-80.
3. Frickhofen N, Abkowitz JL, Safford M, et al. Persistent B19 Parvovirus infection in patients infected with human immunodeficiency virus-1: a treatable cause of anaemia in AIDS. Ann Intern Med 1990;113:926-33.
4. Jordan JA. Diagnosing human parvovirus B19 infection: guidelines for test selection. Molecular Diagnosis 2001;6:307-12.
5. Arribas JR, Pena JM, Echevarria JE. Parvovirus B19-related anemia in on HIV-infected patient; rapid control after production of neutralising antibodies during highly active antiretroviral therapy. Ann Intern Med 2000;132:1011.